Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin for treatment of COVID-19 in Nigerian patients
ISRCTN40302986Phase 3Completed
- Sponsor
- Lagos University Teaching Hospital
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ivermectin in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Lagos University Teaching Hospital. Primary endpoint: Viral RNA load at day 14. Started Jun 2020; status: completed.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ISRCTN40302986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN40302986.